Loading...
Optimising low‐dose methotrexate for rheumatoid arthritis—A review
Methotrexate at low doses (5–25 mg/week) is first‐line therapy for rheumatoid arthritis. However, there is inter‐ and intrapatient variability in response, with contribution of variability in concentrations of active polyglutamate metabolites, associated with clinical efficacy and toxicity. Prescrib...
Na minha lista:
| Udgivet i: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6783593/ https://ncbi.nlm.nih.gov/pubmed/31276602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14057 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|